Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  MorphoSys AG    MOR   DE0006632003

Delayed Quote. Delayed  - 08/26 05:35:20 pm
38.39 EUR   -0.80%
08/17 MORPHOSYS AG : Publication pursuant to §26 sect.1 WpHG (the German S..
08/17 MORPHOSYS AG : Publication pursuant to §26 sect.1 WpHG (the German S..
08/17 MORPHOSYS AG : Publication pursuant to §26 sect.1 WpHG (the German S..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
08/22/2016 08/23/2016 08/24/2016 08/25/2016 08/26/2016 Date
38.995(c) 39.4(c) 39.53(c) 38.7(c) 38.39(c) Last
57 375 79 269 26 007 73 486 48 173 Volume
+2.48% +1.04% +0.33% -2.10% -0.80% Change
More quotes
Financials (€)
Sales 2016 49,6 M
EBIT 2016 -64,3 M
Net income 2016 -47,3 M
Finance 2016 216 M
Yield 2016 -
Sales 2017 61,7 M
EBIT 2017 -46,0 M
Net income 2017 -47,5 M
Finance 2017 122 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 16,2x
EV / Sales2017 14,5x
Capitalization 1 019 M
More Financials
Company
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics and research applications.It operates through the following segments: Partnered Discovery, Proprietary Development and AbD Serotec.The Partnered Discovery segment involves technologies for the generation of human... 
More about the company
Surperformance© ratings of MorphoSys AG
Trading Rating : Investor Rating :
More Ratings
Latest news on MORPHOSYS AG
08/18 MORPHOSYS : "Anti-CD38 Antibody and Lenalidomide Or Bortezomib for the Treatment..
08/17 MORPHOSYS AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Tr..
08/17 MORPHOSYS AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Tr..
08/17 MORPHOSYS AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Tr..
08/17 MORPHOSYS AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Tr..
08/09 MORPHOSYS AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Tr..
08/04 MORPHOSYS : Successfully Completes Safety Run-in of MOR208 in L-MIND Combination..
08/03 MORPHOSYS : Successfully Completes Safety Run-in of MOR208 in L-MIND Combination..
08/01 MORPHOSYS : AG Reports Results for the First Six Months of 2016
07/25 MORPHOSYS : to Host Q2 2016 Conference Call on August 1, 2016
More news
Sector news : Biotechnology & Medical Research - NEC
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/22DJPfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
08/01 MorphoSys' (MPSYF) CEO Simon Moroney on Q2 2016 Results - Earnings Call Trans..
08/01 MorphoSys AG 2016 Q2 - Results - Earnings Call Slides
08/01 MorphoSys AG reports H1'16 results
05/03 MorphoSys' (MPSYF) CEO Simon Moroney on Q1 2016 Results - Earnings Call Trans..
05/03 MorphoSys AG reports Q1 results
Advertisement
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MOR | DE0006632003 | 4-Traders
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 58,3 €
Spread / Average Target 52%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Simon E. Moroney Chief Executive Officer
Gerald Heinz Möller Chairman-Supervisory Board
Jens Holstein Chief Financial Officer
Marlies Sproll Chief Scientific Officer
Steffen Pohlenz Head-Information Technology
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MORPHOSYS AG-31.43%1 141
INCYTE CORPORATION-25.27%15 236
CELLTRION, INC.--.--%11 367
LONZA GROUP AG14.78%10 130
QUINTILES TRANSNATIONA..10.24%8 968
ALKERMES PLC-43.94%6 744
More Results